H.C. Wainwright resumed coverage on Vera Therapeutics with a new price target

5/5/25 9:37:24 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright resumed coverage of Vera Therapeutics with a rating of Buy and set a new price target of $75.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VERA

Date	Price Target	Rating	Analyst
5/5/2025	$75.00	Buy	H.C. Wainwright
2/4/2025	$49.00	Outperform	Wolfe Research
1/28/2025	$58.00	Buy	Goldman
11/21/2024	$70.00	Overweight	Wells Fargo
10/16/2024		Sector Outperform	Scotiabank
1/25/2024	$26.00	Outperform	Oppenheimer
1/8/2024		Overweight	Cantor Fitzgerald
12/18/2023	$29.00	Outperform	Raymond James